A recent study conducted by scientists at the University of Oxford has shed new light on the efficacy of COVID-19 vaccines in mitigating severe illness. 

Published in the journal Nature Communications, the study offers crucial insights into the immune response triggered by COVID-19 vaccines, particularly the ChAdOx1 nCoV-19 vaccine, developed in collaboration with AstraZeneca.